Patents by Inventor Iver Heron

Iver Heron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide
    Patent number: 6613336
    Abstract: Disclosed is an H. influenzae type b polysaccharide-meningococcal outer membrane protein conjugate, pharmaceutical compositions thereof, and the use thereof to induce an immune response to H. influenzae in an animal.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: September 2, 2003
    Assignee: Baxter International Inc.
    Inventors: Milan S. Blake, Francis Michon, Peter C. Fusco, Iver Heron
  • Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide
    Publication number: 20020131984
    Abstract: Disclosed is an H. influenzae type b polysaccharide-meningococcal outer membrane protein conjugate, pharmaceutical compositions thereof, and the use thereof to induce an immune response to H. influenzae in an animal.
    Type: Application
    Filed: May 10, 2002
    Publication date: September 19, 2002
    Inventors: Milan S. Blake, Francis Michon, Peter C. Fusco, Iver Heron
  • Immunogenic conjugates comprising a Group B meningococcal porin and an H influenzae polysaccharide
    Patent number: 6451317
    Abstract: Disclosed is an H. influenzae type b polysaccharide-meningococcal outer membrane protein conjugate, pharmaceutical compositions thereof, and the use thereof to induce an immune response to H. influenzae in an animal.
    Type: Grant
    Filed: July 17, 1998
    Date of Patent: September 17, 2002
    Assignee: Baxter International Inc.
    Inventors: Milan S. Blake, Francis Michon, Peter C. Fusco, Iver Heron
  • Pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane
    Patent number: 5942237
    Abstract: A novel type of formulation for the topical administration of antigens and/or vaccines to mammals via mucosal membranes comprising one or more adjuvants/vehicles selected from (a) polyoxyethylene sorbitan monoesters, (b) polyoxyethylene castor oil, (c) caprylic/capric acid glycerides and (d) gangliosides in an amount of 0.01 to 15% (v/v) calculated on the total volume of the preparation. This formulation enhances the immunological response n a mammal following mucosal administration, e.g. nasal, oral, rectal or vaginal application.
    Type: Grant
    Filed: October 6, 1995
    Date of Patent: August 24, 1999
    Assignee: Lyfjathroun H.F.
    Inventors: Sveinbjorn Gizurarson, Iver Heron